Anti-Immunoglobulin E (Omalizumab) Therapy in Allergic Asthma (Q34435281)
scientific article published on October 15, 2001
Language:
Current Data About Anti-Immunoglobulin E (Omalizumab) Therapy in Allergic Asthma
(P31) (Q13442814)
(P248)
(P698) 11704612
(P813) Wednesday, August 2, 2017

(P304) S12-7
(P248)
(P698) 11704612
(P813) Wednesday, August 2, 2017

(P407) (Q1860)

(P433) 8 Pt 2
(P248)
(P698) 11704612
(P813) Wednesday, August 2, 2017

(P478) 164
(P248)
(P698) 11704612
(P813) Wednesday, August 2, 2017

(P577) Monday, October 1, 2001
(P248)
(P698) 11704612
(P813) Wednesday, August 2, 2017

Monday, October 15, 2001
(P248)
(P698) 11704612
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11704612
(P813) Monday, January 27, 2025

(P921) (Q35869)

(Q12301086)
(P887)

(P953) https://www.atsjournals.org/doi/pdf/10.1164/ajrccm.164.supplement_1.2103026
(P248)
(P356) 10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P854) https://api.crossref.org/works/10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P813) Monday, January 27, 2025

(P1433) (Q4744267)
(P248)
(P698) 11704612
(P813) Wednesday, August 2, 2017

(P1476) "Anti-immunoglobulin E (omalizumab) therapy in allergic asthma" (language: en)
(P248)
(P698) 11704612
(P813) Wednesday, August 2, 2017

"Anti-Immunoglobulin E (Omalizumab) Therapy in Allergic Asthma" (language: en)
(P248)
(P356) 10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P854) https://api.crossref.org/works/10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P813) Monday, January 27, 2025

(P2093) W. W. Busse
(P1545) 1
(P248)
(P698) 11704612
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11704612
(P813) Monday, January 27, 2025

(P2860) (Q41688272)
(P248)
(P854) https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103026
(P813) Sunday, January 21, 2018

(Q53535114)
(P248)
(P854) https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103026
(P813) Sunday, January 21, 2018

(Q73588501)
(P1545) 1
(P248)
(P356) 10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P854) https://api.crossref.org/works/10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P813) Monday, January 27, 2025

(Q7743550)
(P1545) 2
(P478) 99
(P304) S102
(P2093) Togias A
(P577) Wednesday, January 1, 1997
(P248)
(P356) 10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P854) https://api.crossref.org/works/10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P813) Monday, January 27, 2025

(Q73442941)
(P1545) 3
(P248)
(P356) 10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P854) https://api.crossref.org/works/10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P813) Monday, January 27, 2025

(Q73442944)
(P1545) 4
(P248)
(P356) 10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P854) https://api.crossref.org/works/10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P813) Monday, January 27, 2025

(P13046) (Q7318358)
(P248)

other details
description scientific article published on October 15, 2001

External Links
(P356) 10.1164/AJRCCM.164.SUPPLEMENT_1.2103026
(P698) 11704612